Suppr超能文献

苄非他明给药后苯丙胺和甲基苯丙胺的检测。

Detection of amphetamine and methamphetamine following administration of benzphetamine.

作者信息

Cody J T, Valtier S

机构信息

Clinical Research Squadron, 59th Medical Wing, Lackland AFB, Texas 78236-5319, USA.

出版信息

J Anal Toxicol. 1998 Jul-Aug;22(4):299-309. doi: 10.1093/jat/22.4.299.

Abstract

Interpretation of urine drug-testing results is a challenging endeavor for several reasons. Effects of pH, dilution, legitimate and illicit sources of the drugs, and, perhaps the most challenging, the possibility of the methamphetamine and/or amphetamine being the result of the use of some other drug. Although it is known that 14 different compounds are metabolized to methamphetamine or amphetamine or both, there is little information on the metabolic profile of many of these compounds, making interpretation of results difficult. Benzphetamine, administered as a single Didrex tablet, was given to 10 subjects (7 male and 3 female) and urine samples collected for the next 7 days. Gas chromatography-mass spectrometry results showed 3 of the 10 subjects did not have a single urine sample that exceeded a 500-ng/mL cutoff for amphetamine or methamphetamine. The other subjects had between one and six samples that tested positive at or above that level. Two subjects excreted more methamphetamine than amphetamine, whereas the other eight excreted greater amounts of amphetamine than methamphetamine. The observed ratio between amphetamine and methamphetamine was significantly different than what would be expected from the use of methamphetamine. Results of this study indicate the metabolism of benzphetamine to desmethylbenzphetamine is a major pathway in the metabolism of the drug. Enantiomer analysis of the methamphetamine and amphetamine revealed only the d-enantiomer. Results of this study add significant information useful to interpret the possibility of benzphetamine as the origin of methamphetamine and amphetamine in urine samples.

摘要

由于多种原因,解读尿液药物检测结果是一项具有挑战性的工作。尿液酸碱度、稀释程度、药物的合法与非法来源,以及可能最具挑战性的是,甲基苯丙胺和/或苯丙胺可能是使用其他某种药物的结果。尽管已知有14种不同的化合物会代谢为甲基苯丙胺或苯丙胺或两者皆有,但关于其中许多化合物的代谢谱信息却很少,这使得结果解读变得困难。给10名受试者(7名男性和3名女性)服用一片Didrex牌苄非他明,然后在接下来的7天收集尿液样本。气相色谱-质谱分析结果显示,10名受试者中有3人的尿液样本中苯丙胺或甲基苯丙胺含量均未超过500纳克/毫升的临界值。其他受试者有1至6个样本检测呈阳性,且达到或超过该水平。两名受试者排出的甲基苯丙胺比苯丙胺多,而其他八名受试者排出的苯丙胺比甲基苯丙胺多。观察到的苯丙胺与甲基苯丙胺的比例与使用甲基苯丙胺时预期的比例显著不同。这项研究的结果表明,苄非他明代谢为去甲基苄非他明是该药物代谢的主要途径。对甲基苯丙胺和苯丙胺的对映体分析仅显示出右旋对映体。这项研究的结果为解读尿液样本中苄非他明作为甲基苯丙胺和苯丙胺来源的可能性增添了重要信息。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验